OmniAb is a leading-edge antibody discovery company that offers a wide range of innovative services. With a strong focus on expertise and cutting-edge technologies, OmniAb provides pharmaceutical industry partners with access to diverse antibody repertoires and advanced screening technologies. By choosing OmniAb for antibody discovery, partners gain the advantage of the most comprehensive and clinically proven suite of discovery technologies available.

OmniAb's transgenic animal platforms, particularly OmniChicken, offer a unique innovation. Chickens, being evolutionarily distant from rodents, produce stronger and more diverse antibody responses to various target antigens, making them ideal hosts for therapeutic antibody discovery. OmniAb keeps up with the latest advancements in the field and continually publishes news, press releases, and presentations about their technology.

With a diverse portfolio of over 65 biopharmaceutical companies and research institutions, OmniAb has established itself as a trusted partner in advancing clinical drug development. Contact OmniAb today to learn more about their antibody discovery services and find the solution that best suits your needs